Trial intelligence / Profile preview

Comparative outcome of lidocaine and bupivacaine for cervical medial branch block in chronic cervical facet arthropathy

TCTR20210404001Phase 4Recruiting

Sponsor
Faculty of Medicine, Chulalongkorn University
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lidocaine, bupivacaine in Cervical facet arthrosis (CFA), sponsored by Faculty of Medicine, Chulalongkorn University. Started Mar 2021; status: recruiting.

02

Drugs

lidocainebupivacaine
03

Conditions

Cervical facet arthrosis (CFA)

Beyond the preview

Go deeper on TCTR20210404001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210404001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call